Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anaplastic myeloma

K Zervas1, N Constantinou, M Karakantza

  • 1Haematology Department, Cancer Hospital, Theaganion, Thessaloniki, Greece.

Leukemia & Lymphoma
|February 1, 1995
PubMed
Summary

Anaplastic myeloma (AM), a rare multiple myeloma (MM) variant, presents unique challenges. This case highlights extramedullary disease without initial MM diagnosis, resistant to standard radio-chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of anti-D immunoglobulin prophylaxis in solid organ transplants.

Transfusion medicine (Oxford, England)·2014
Same author

Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference?

QJM : monthly journal of the Association of Physicians·2013
Same author

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia.

Bone marrow transplantation·2010
Same author

Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease.

Bone marrow transplantation·2010
Same author

Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke.

European journal of neurology·2010

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Anaplastic myeloma (AM) is an aggressive subtype of multiple myeloma (MM).
  • Extramedullary involvement in AM can precede or occur without a primary diagnosis of MM.
  • Prognosis for AM is generally poor, necessitating understanding of its varied presentations.

Observation:

  • A unique case of AM is presented with initial manifestations solely due to extramedullary disease.
  • The patient lacked an initial diagnosis of multiple myeloma.
  • Morphological and immunocytochemical analyses were crucial for differential diagnosis.

Findings:

  • The extramedullary anaplastic myeloma sites showed resistance to radio-chemotherapy.
  • The case underscores the diagnostic complexity of AM presenting with extramedullary disease.
  • Immunocytochemistry confirmed the diagnosis despite atypical presentation.

Implications:

  • This case highlights the importance of considering AM in extramedullary presentations, even without a prior MM diagnosis.
  • Treatment strategies may need to be adapted for AM with extramedullary involvement.
  • Further research into the biology and treatment of AM is warranted.

Related Experiment Videos